Agilent Technologies Inc (A) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Agilent Technologies Inc (A) has a cash flow conversion efficiency ratio of 0.057x as of July 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($362.00 Million) by net assets ($6.37 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how leveraged is Agilent Technologies Inc's balance sheet to measure how much of total assets are equity-financed.
Agilent Technologies Inc - Cash Flow Conversion Efficiency Trend (1998–2025)
This chart illustrates how Agilent Technologies Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Agilent Technologies Inc cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
Agilent Technologies Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Agilent Technologies Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
PayPal Holdings Inc
NASDAQ:PYPL
|
0.057x |
|
JD.com Inc Adr
NASDAQ:JD
|
0.071x |
|
CTBC Financial Holding Co Ltd
TW:2891
|
0.246x |
|
CSL LTD SPON.ADR 2
F:CSJA
|
N/A |
|
ArcelorMittal SA
XETRA:ARRD
|
0.000x |
|
WEG S.A.
SA:WEGE3
|
0.066x |
|
ArcelorMittal SA
MC:MTS
|
0.000x |
|
Deutsche Börse AG
XETRA:DB1
|
0.124x |
Annual Cash Flow Conversion Efficiency for Agilent Technologies Inc (1998–2025)
The table below shows the annual cash flow conversion efficiency of Agilent Technologies Inc from 1998 to 2025. For the full company profile with market capitalisation and key ratios, see A company net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-10-31 | $6.74 Billion | $1.56 Billion | 0.231x | -22.10% |
| 2024-10-31 | $5.90 Billion | $1.75 Billion | 0.297x | -2.07% |
| 2023-10-31 | $5.84 Billion | $1.77 Billion | 0.303x | +22.58% |
| 2022-10-31 | $5.30 Billion | $1.31 Billion | 0.247x | -10.25% |
| 2021-10-31 | $5.39 Billion | $1.49 Billion | 0.276x | +45.80% |
| 2020-10-31 | $4.87 Billion | $921.00 Million | 0.189x | -12.11% |
| 2019-10-31 | $4.75 Billion | $1.02 Billion | 0.215x | -9.57% |
| 2018-10-31 | $4.57 Billion | $1.09 Billion | 0.238x | +29.33% |
| 2017-10-31 | $4.83 Billion | $889.00 Million | 0.184x | -1.60% |
| 2016-10-31 | $4.24 Billion | $793.00 Million | 0.187x | -41.23% |
| 2015-10-31 | $4.16 Billion | $1.32 Billion | 0.318x | +135.76% |
| 2014-10-31 | $5.29 Billion | $713.00 Million | 0.135x | -38.08% |
| 2013-10-31 | $5.29 Billion | $1.15 Billion | 0.218x | -8.03% |
| 2012-10-31 | $5.18 Billion | $1.23 Billion | 0.237x | -18.87% |
| 2011-10-31 | $4.32 Billion | $1.26 Billion | 0.292x | +32.68% |
| 2010-10-31 | $3.24 Billion | $712.00 Million | 0.220x | +35.14% |
| 2009-10-31 | $2.51 Billion | $408.00 Million | 0.163x | -44.89% |
| 2008-10-31 | $2.56 Billion | $756.00 Million | 0.295x | -1.40% |
| 2007-10-31 | $3.23 Billion | $969.00 Million | 0.300x | +72.92% |
| 2006-10-31 | $3.66 Billion | $634.00 Million | 0.173x | -21.34% |
| 2005-10-31 | $4.08 Billion | $899.00 Million | 0.220x | +17.35% |
| 2004-10-31 | $3.57 Billion | $670.00 Million | 0.188x | +468.15% |
| 2003-10-31 | $2.82 Billion | $-144.00 Million | -0.051x | +52.62% |
| 2002-10-31 | $4.63 Billion | $-498.00 Million | -0.108x | -140.55% |
| 2001-10-31 | $5.66 Billion | $1.50 Billion | 0.265x | +66.76% |
| 2000-10-31 | $5.26 Billion | $838.00 Million | 0.159x | +16.77% |
| 1999-10-31 | $3.38 Billion | $461.00 Million | 0.136x | -45.15% |
| 1998-10-31 | $3.02 Billion | $751.00 Million | 0.249x | -- |
About Agilent Technologies Inc
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrome… Read more